Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:4.2.3.23 (GAS)
 957 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The Streptococcus pyogenes (group A streptococci, GAS) stand-alone Mga regulator has been shown to positively control surface-expressed virulence factors like the antiphagocytic M protein during exponential growth phase and thus, was implicated to contribute to the acute infection process. In the present study, we generated mga mutants as well as mga promoter - luciferase reporter fusions in weakly and strongly encapsulated serotype M2 and M49 GAS strains. Employing the luc reporter fusions, we showed that the complex growth medium THY-broth decreased mga expression and identified albumin as one component responsible for this effect. Fibrinogen and cU50980omponents of the complex DMEM cell culture medium induced the mga transcription rate. The attachment of mga mutants to immobilized human matrix proteins (collagen type I, fibronectin, keratin, laminin) and serum proteins (albumin, fibrinogen) was consistently reduced. Changing the Mn(2+) or Ca(2+) growth medium concentrations did not affect the fibronectin/collagen binding of M49 GAS wild-type and mga mutant strains. Medium supplementation with the oxidative stressor paraquat or anaerobic growth on THY-agar led to a relatively increased human matrix protein binding of the mga mutant. Opposite to their matrix protein-binding behaviour, the M2 and M49 mga mutants displayed an increased attachment and internalization rate for eukaryotic cells. The host cell viability was considerably reduced after prolonged exposure to mga mutants. By generating and testing corresponding M protein gene (emm) mutants, features of the eukaryotic cell interaction could not be associated to the Mga - M protein regulatory axis. In conclusion, the present results support the postulated central role of Mga regulation for GAS host colonization and acute infection stages.
 ...
PMID:Impact of the Streptococcus pyogenes Mga regulator on human matrix protein binding and interaction with eukaryotic cells. 2009 32

Lagos bat virus (LBV) is a phylogroup II lyssavirus exclusively found in Africa. Previous studies indicated that this virus is lethal to mice after intracranial and intramuscular inoculation. The antigenic composition of LBV differs substantially from that of rabies virus (RABV) and current rabies vaccines do not provide cross protection against phylogroup II lyssaviruses. To investigate the potential role of the LBV matrix protein (M) and glycoprotein (G) in pathogenesis, reverse genetics technology was used to construct recombinant viruses. The genes encoding the glycoprotein, or the matrix and glycoprotein of the attenuated RABV strain SPBN, were replaced with those of LBV resulting in SPBN-LBVG and SPBN-LBVM-LBVG, respectively. To evaluate the immunogenicity of the LBV G, the recombinant RABV SPBNGAS-LBVG-GAS was constructed with the LBV G inserted between two mutated RABV G genes (termed GAS). All the recombinant viruses were lethal to mice after intracranial (i.c.) inoculation although the pathogenicity of SPBNGAS-LBVG-GAS was lower compared to the other recombinant viruses. Following intramuscular (i.m.) inoculation, only SPBN-LBVM-LBVG was lethal to mice, indicating that both the M and G of LBV play a role in the pathogenesis. Most interestingly, serum collected from mice that were inoculated i.m. with SPBNGAS-LBVG-GAS neutralized phylogroup I and II lyssaviruses including RABV, Duvenhage virus (DUVV), LBV, and Mokola virus (MOKV), indicating that this recombinant virus has potential to be developed as a pan-lyssavirus vaccine.
 ...
PMID:Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine. 3027 Aug 94